edited by Ron Mann
Pharmacovigilance is a single reference detailing the issues and current status of the necessity, safety, and effectiveness of pharmaceuticals today.
Pharmacovigilance is clearly structured and covers all the important areas of the subject including:
- legal aspects
- drug regulatory requirements
- methods of signal generation
- reporting schemes
- pharmacovigilance in selected system-organ classes
- future directions
Contents:
- Basis of Pharmacovigilance
- Introduction
- Legal Basis - EU
- Legal Basis - US
- Ethical Oversight, Consent and Confidentiality
- Preclinical Safety Evaluation
- Metabolic Mechanisms
- Drugs and the Elderly
- Natural History
- Responding to Signals
- Micturin and Torsades de Pointes
- Withdrawal of Terodiline: A Tale of Two Toxicities
- Nomifensine and Haemolytic Anaemia
- Signal Generation
- WHO Program - Global Monitoring
- Regulatory Pharmacovigilance in the EU
- Spontaneous Reporting - UK
- Spontaneous Reporting - France
- Spontaneous Reporting - USA
- Algorithms
- Overview - Spontaneous Signalling
- Statistical Methods of Signal Detection
- Statistical Methods of Evaluating Pharmacovigilance Data
- Data Mining
- Epidemiology of Adverse Events Associated with Epilepsy and Use of Lamotrigine
- Pharmacovigilance in the Netherlands
- CIOMS Working Groups and their Contribution to Pharmacovigilance
- PEM in the UK
- PEM in New Zealand
- MEMO in the UK
- GPRD in the UK
- Overview of North American Databases
- Pharmacovigilance in the HMO Research Network
- Other Databases in Europe
- Surveillance for Medical Devices - USA
- Pharmacovigilance and Selected System Organ Classes
- Dermatological ADRs
- Gastrointestinal ADRs
- Haematological ADRs
- Hepatic Adverse Drug Reactions
- Ocular ADRs
- Drug Safety in Pregnancy
- ADRs and Drug Safety 1999-2000
- Lessons and Directions
- Teaching Pharmacovigilance
- Medical Errors and Lessons from Drug-Related Deaths
- Pharmacogenetics and the Genetic Basis of ADRs
- Keynote Clinical Lessons from Pharmacovigilance
Index